“Febuxostat and Renal Outcomes in Stage 3-4 CKD Patients with Asymptomatic Hyperuricemia: A Prospective Observational Study”, J Rang Med Col., vol. 11, no. 1, pp. 3–8, May 2026, doi: 10.3329/jrpmc.v11i1.89919.